Clinical Trials Browser

Completed × Breast Neoplasms × paclitaxel poliglumex × Clear all

NCT00265733 2016-12-06

Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT00270907 2013-02-13

CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer

Phase 1 Completed

Breast Neoplasms

NCT00148707 2007-12-21

Study of Xyotax (CT-2103) in Patients With Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms